Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
about
Interleukin (IL)-4 -590C>T polymorphism is not associated with the susceptibility of gastric cancer: An updated meta-analysisRole of cancer-associated fibroblasts in invasion and metastasis of gastric cancerLong non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancerDecreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer.Why should we perform a D2 lymphadenectomy in gastric cancer?
P2860
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@ast
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@en
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@nl
type
label
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@ast
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@en
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@nl
prefLabel
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@ast
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@en
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@nl
P2093
P2860
P1476
Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis.
@en
P2093
P2860
P356
10.1016/J.AMSU.2014.03.003
P577
2014-03-20T00:00:00Z